Delivery Order SPE2DE24D0021-SPE2D626F01NB
- Not listed
- Fisher Scientific Company L.L.C. received a delivery order valued at $28,623.50 from the Department of Defense Medical Supply Chain for System PCR IV 1st Strain Superscript 50 Reaction kits, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was awarded on November 5, 2025, with no set-aside designation, indicating open competition. The supplies will be delivered to Pittsburgh, Pennsylvania. This delivery order represents a child...
- Fisher Scientific Company L.L.C. was awarded a $4,010.00 fixed-price delivery order with economic price adjustment authority by the Department of Defense's Medical Supply Chain on December 30, 2025, for RT-PCR RNA/DNA polymer kit components with ultimate completion by January 14, 2026. The award, executed through a child contract arrangement at the Pittsburgh, Pennsylvania location, represents a routine procurement of specialized molecular diagnostic supplies supporting federal healthcare and...
- Fisher Scientific Company L.L.C. received a $4,178.20 fixed-price delivery order from the Department of Defense's Medical Supply Chain on January 10, 2026, for Kit RT PCR DNA Polymer 1 Step Superscipt3 Platin, with final delivery required by January 29, 2026. The award was issued without set-aside designation, indicating open competition. This delivery order represents a child contract under a larger indefinite delivery vehicle, enabling the Department of Defense to procure specialized molecular...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,560.26 by the Department of Defense's Medical Supply Chain for RT-PCR reverse transcriptase reagents with reduced ribonuclease activity, with a final completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating competition in an open federal procurement environment. The contract represents a child order under a larger vehicle,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,167.00 by the Department of Defense's Medical Supply Chain for RGT RT PCR ROX AGPATH-ID ARRAYSCRIPT AMP diagnostic products. Awarded on November 5, 2025, with an ultimate completion date of November 21, 2025, this fixed-price contract with economic price adjustment represents a child order under a larger procurement vehicle. The award carries no set-aside designation, indicating Fisher Scientific competed in an...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,560.56 on December 18, 2025, for the supply of a PCR DNA polymerase kit, single-step substrate, and a 3-well plate configuration. This fixed-price delivery order with economic price adjustment serves the Department of Defense's Medical Supply Chain and is scheduled for completion by January 12, 2026. The contract was awarded without set-aside designation, indicating open competition. Performance will occur at the...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $4,280.28 from the Department of Defense's Medical Supply Chain for one kit of reverse transcription polymerase chain reaction (RT-PCR) DNA polymerase with a SuperScript3 platinum formulation. The award, issued on December 15, 2025, is expected to be completed by January 6, 2026, with performance occurring in Pittsburgh, Pennsylvania. This delivery order was issued without set-aside designation, indicating Fisher...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract by the Department of Defense Medical Supply Chain for a Kit RT PCR RNA DNA Polymer with a ceiling value of $1,604.00. The award was issued on October 30, 2025, with an ultimate completion date of November 14, 2025. This fixed-price contract with economic price adjustment represents a child contract under a larger procurement vehicle and involves no set-aside designation, indicating competition in an open federal...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $2,748.00 for the provision of RT PCR RNA test kits with built-in hot start gel from the Department of Defense's Medical Supply Chain. The contract, awarded on November 6, 2025, is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 21, 2025. This delivery order represents a child contract with no set-aside designation, indicating open competition in the...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $2,485 by the Department of Defense's Medical Supply Chain on December 15, 2025, for SSIII 1-Step QRT-PCR 100 diagnostic test supplies. The contract, which is a child order under a larger vehicle, has an ultimate completion date of January 7, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents routine procurement of quantitative reverse transcription polymerase chain reaction...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F01NBDelivery Order
Fisher Scientific Company L.L.C. was awarded a $27,478.56 fixed-price delivery order by the Department of Defense Medical Supply Chain on January 12, 2026, for PCR IV 1st Strain Superscript 50 reaction kits, with performance completion expected by January 27, 2026. The contract was issued without set-aside designation, indicating open competition. This delivery order represents a child contract under a larger procurement vehicle, leveraging Fisher Scientific's established position as a critical supplier of laboratory and medical products to federal agencies. The company, headquartered in Pittsburgh, Pennsylvania, and registered in the System for Award Management since July 2001, brings extensive expertise in providing specialized laboratory equipment, diagnostic systems, and scientific reagents across multiple federal departments. This award reflects Fisher Scientific's proven capability as a preferred vendor to the Department of Defense for specialized molecular biology and diagnostic supplies. The company maintains substantial federal procurement relationships, including a $1.65 million Blanket Purchase Agreement with the Department of Veterans Affairs extending through September 2030 for toxicology and drugs of abuse reagents, and numerous delivery orders from the VA and civilian agencies including the National Heart, Lung, and Blood Institute and the Indian Health Service. The PCR reagent order supports the department's laboratory diagnostic operations and demonstrates continued confidence in Fisher Scientific's ability to deliver critical supplies supporting federal healthcare and research missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 1/11/26 |